Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy (Q44370016)

2 December 2017

Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy (English)

1 reference

2 December 2017

2

1 reference

2 December 2017

Jong Jin Oh

1

1 reference

2 December 2017

Sangchul Lee

series ordinal

3

1 reference

2 December 2017

Seung June Sohn

series ordinal

4

1 reference

2 December 2017

Sang Eun Lee

series ordinal

5

1 reference

2 December 2017

29 September 2012

1 reference

International Urology and Nephrology

2 December 2017

1 reference

2 December 2017

45

1 reference

2 December 2017

1

1 reference

2 December 2017

121-127

1 reference

Diabetes mellitus and risk of prostate cancer: a meta-analysis

2 December 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

The protective effect of diabetes mellitus against prostate cancer: role of sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Is body mass index associated with pathological outcomes after radical prostatectomy in Korean men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Hormonal profile of diabetic men and the potential link to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Mortality from site-specific malignancies in type 2 diabetic patients from Verona

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Abnormal glucose tolerance and the risk of cancer death in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Glycemic control and prostate cancer progression: results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0306-X

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

21 January 2018

1 reference

12 December 2020

Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02

1 reference

12 December 2020

Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?

1 reference

12 December 2020

A meta-analysis of diabetes mellitus and the risk of prostate cancer

1 reference

12 December 2020

Impact of diabetes mellitus on outcomes in patients with colon cancer

1 reference

12 December 2020

10.1007/S11255-012-0306-X

Identifiers

DOI

1 reference

2 December 2017

1 reference